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in!the!mouth:!probing!depth!(PD):!measured!from!the!free!gingival!margin!to!the!bottom!of!the!sulcus;!clinical!attachment!level!(CAL):!measured!from!the!cementoQenamel!junction!to!the!bottom!of!the!sulcus;!recession!(REC):!measured!as!the!distance!from!the!free!gingival!margin!to!the!cementoQenamel!junction;!bleeding!on!probing!(BOP):!measured!as!yes!or!no.!!Six!sites!were!measured!around!each!tooth!(mesiobuccal,!buccal,!distobuccal,!distolingual,!lingual,!and!mesiolingual).!!Periapical!and!bitewing!radiographs!were!taken!of!each!surgical!site!(2!films/site)!if!the!patient!did!not!have!them!taken!within!6!months!of!the!surgical!appointment.!!A!full!mouth!radiographic!series!was!taken!if!the!patient!had!not!had!one!within!the!past!24!months.!!! b. Study!Design!! i. Serum!and!Gingival!Crevicular!Fluid!Collection!!Immediately!prior!to!periodontal!surgery,!blood!samples!were!obtained!from!each!patient!by!venipuncture!and!centrifuged!to!separate!serum!from!blood!cells.!!The!serum!was!then!separated!into!two!test!tubes!and!stored!in!an!Q80°C!freezer!until!completion!of!patient!enrollment.!!!!After!venous!blood!collection,!gingival!crevicular!fluid!(GCF)!was!collected!from!one!healthy!and!one!diseased!site!from!each!patient.!!A!diseased!site!was!defined!as!having!a!PD!≥!6mm,!CAL!≥!6mm!and!BOP;!this!site!was!later!designated!as!the!site!
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To!explore!the!doseQdependent!impact!of!vitamin!D!levels!with!regard!to!clinical!outcomes,!we!evaluated!the!relationship!between!each!patient’s!serum!vitamin!D!level!and!clinical!parameter!improvements!using!linear!regression!analysis!(Figures!2!and!3).!!Serum!vitamin!D!level!was!positively!correlated!with!PD!reduction!at!the!6Qmonth!(p!=!0.001)!and!12Qmonth!(p!=!0.005)!time!points.!!Additionally,!we!found!significant!correlations!between!serum!vitamin!D!level!and!6Qmonth!CAL!gain!(p!=!0.02),!as!well!as!12Qmonth!radiographic!linear!bone!gain!(p!=!0.04).!!There!were!no!other!significant!correlations!for!other!time!points!or!other!clinical!outcomes.!! ! c. GCF!and!Serum!Biomarkers!Related!to!Vitamin!D!Status!!We!wanted!to!determine!if!biomarkers!levels!within!the!local!oral!environment!or!within!systemic!circulation!were!influenced!by!serum!vitamin!D!concentration.!!Linear!regression!analysis!revealed!that!baseline!serum!vitamin!D!levels!were!highly!significantly!correlated!to!GCF!levels!of!MER!(p<0.!001)!and!SDFQ1!(p<0.001).!!Analysis!of!the!other!biomarkers!from!the!GCF!and!biomarkers!from!the!serum!failed!to!show!significant!correlations.!!See!Tables!2!and!3.!! d. SubQgroup!Analysis!!Because!of!the!heterogeneity!within!the!study!population!with!regard!to!type!of!surgery,!surgical!tooth!type,!tooth!location,!we!wanted!to!test!if!the!outcomes!from!the!pooled!population!remained!evident!within!subQgroups.!!
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!! i. Surgical!Type:!Resective!or!Regenerative!! !!Within!the!resective!surgical!group,!PD!reduction!was!significantly!greater!in!the!SUF!group!(2.8!±!1.1!mm)!compared!to!the!DEF!group!(1.4!±!0.8!mm)!at!the!6Qmonth!time!point!(p!=!0.002).!Additionally,!we!found!that!PD!reduction!significantly!correlated!with!serum!vitamin!D!concentration!at!6!months!(p!=!0.01,!r!=!0.19)!and!12!months!(p!=!0.048,!r!=!0.07).!!Considering!the!group!receiving!regenerative!surgery,!SUF!patients!had!significantly!more!CAL!gain!at!6!months!compared!to!DEF!patients!(3.1!±!1.9!mm!vs.!0.5!±!0.7!mm,!p!=!0.03).!!Linear!bone!gain!(ACHQCEJ)!was!also!significantly!positively!correlated!with!serum!vitamin!D!levels!at!12!months!(p!=!0.01,!r!=!0.80).!! ii. Tooth!Location:!Maxillary!or!Mandibular!!For!study!sites!located!in!the!maxilla,!SUF!patients!had!significantly!greater!PD!reduction!at!12!months!when!compared!to!DEF!patients!(2.5!±!1.4!mm!vs.!1.4!±!0.9!mm,!p!=!0.02).!!PD!reduction!from!maxillary!study!sites!was!significantly!positively!correlated!to!serum!vitamin!D!level!at!12!months!(p=0.03,!r!=!0.13).!!!For!study!sites!in!the!mandible,!significantly!greater!(p!=!0.002)!PD!reduction!was!seen!at!6!months!for!SUF!patients!(3.6!±!1.6!mm)!when!compared!to!DEF!patients!
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VEGF!Vascular!endothelial!growth!factor!(VEGF)!plays!a!role!in!the!formation!of!new!blood!vessels.!!It!is!often!expressed!by!oxygenQdeficient!cells!as!a!means!to!increase!blood!circulation!and!oxygenation.!Its!overexpression!can!lead!to!disease,!with!high!levels!of!VEGF!being!demonstrated!at!periodontal!disease!sites!when!compared!with!healthy!sites!(90).!!In!addition!to!its!vascular!effects,!VEGF!may!play!a!role!in!osteoblast!differentiation!(91).!!!! III. Materials!and!Methods!!!The!University!of!Michigan!Institutional!Review!Board!approved!the!study,!which!was!conducted!from!September!2011!through!December!2013.!!All!participants!signed!written!informed!consents!prior!to!participation!in!the!study.!!The!details!of!the!full!investigation!are!provided!in!a!previous!section!of!this!manuscript.!!In!brief,!65!patients!received!periodontal!flap!surgery!and!were!evaluated!for!one!year.!!The!primary!outcome!variable!was!the!change!in!clinical!parameters!(i.e.!probing!depth![PD]!reduction,!clinical!attachment!level![CAL]!gain,!gingival!recession![REC],!and!linear!bone!gain),!comparing!vitamin!D!sufficient!(SUF)!patients!to!vitamin!D!deficient!(DEF)!patients.!!A!secondary!analysis!was!then!completed!to!evaluate!the!impact!of!baseline!serum!and!gingival!crevicular!fluid!biomarker!levels!on!clinical!outcomes!(PD!reduction,!CAL!gain,!and!REC)!after!periodontal!surgery.!! !
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a. Serum!and!Gingival!Crevicular!Fluid!Collection!!Immediately!prior!to!periodontal!surgery,!venous!blood!samples!were!obtained!from!each!patient,!centrifuged,!separated!into!two!test!tubes!and!stored!in!an!Q80°C!freezer!until!completion!of!patient!enrollment.!!GCF!was!then!collected!from!one!healthy!(≤4mm!PD!with!no!BOP)!and!one!diseased!site!(≥6mm!PD!+!BOP;!designated!as!“study!site”)!from!each!patient.!Prior!to!collection,!the!site!was!isolated!and!dried,!and!supragingival!plaque!was!removed!using!a!sterile!instrument.!!A!methylcellulose!strip!(Periopaper®!Gingival!Fluid!Collection!Strips,!Pro!flow,!Inc.,!Amityville,!NY,!USA)!was!inserted!one!millimeter!into!the!sulcus/pocket!for!10!seconds.!!GCF!volume!was!immediately!determined!using!a!calibrated!Periotron!6000!(Harco!Electronics,!Tustin,!CA,!USA).!!GCF!strips!were!then!placed!in!vials,!labeled!and!stored!at!Q80°C!until!processing.!! b. Surgical!Procedure!and!FollowQUp!Visits!!Surgical!therapy!was!performed!and!consisted!of!either!resective!or!regenerative!therapy.!!Clinical!parameters!(PD,!REC,!CAL,!and!bleeding!on!probing![BOP])!were!recorded!at!3,!6!and!12!months!visits!following!surgery.!!Radiographs!of!the!surgical!area!(one!periapical!film,!one!bitewing!film)!were!taken!at!12!months.!!!!
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Age-(mean,!yrs)! 54.1!±!10.6! 59.8!±!9.9! NSD!
Gender! ! ! !
Male! 10!(55.6%)! 29!(61.7%)! NSD!
Female! 8!(44.4%)! 18!(38.3%)! NSD!
Race! ! ! !
Caucasian! 8!(44.4%)! 41!(87.2%)! NSD!
AfricanEAmerican! 7!(38.9%)! 3!(6.4%)! NSD!
Asian! 2!(11.1%)! EE! NSD!
Hispanic! EE! 2!(4.3%)! NSD!
Other! 1!(5.6%)! 1!(2.1%)! NSD!
25GHydroxyvitamin-D--
(mean,!ng/mL)! 16.7!±!1.8! 35.1!±!12.9! p<0.05!
Smoking(Status! ! ! !
Current'smoker! 4"(22.2%)! 12#(25.5%)! NSD!
Former/Never)smoker! 14#(77.8%)! 35#(74.5%)! NSD!
Clinical'Measurements! ! ! !
Probing(Depth! 6.5$±$1.2! 6.8$±$1.0! NSD!
Recession! 0.8$±$2.1! 0.3$±$1.8! NSD!
Clinical'Attachment'Level! 7.4$±$2.2! 7.1$±$2.0! NSD!
Radiographic+Defect+Depth! 2.8$±$1.0! 2.6$±$1.3! NSD!
Mean%Examination%Time%% % % !3BMonth! 3.3!±!0.7! 3.5!±!0.6! NSD!6BMonth! 6.7!±!1.2! 6.7!±!1.1! NSD!12BMonth! 12.5!±!1.0! 12.8!±!1.3! NSD!
!46!!


























12+month)CAL)Gain) ILA6sR) 0.03) 0.0744)
12+month)CEJ+ACH) ILA10) 0.007) 0.163)
Serum,Biomarkers)
12+month)PD)Reduction) ILA6sR) 0.005) 0.1306)
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APPENDIX!1.!!Informed!Consent!Form!
UNIVERSITY OF MICHIGAN 
CONSENT TO BE PART OF A RESEARCH STUDY 
 
INFORMATION ABOUT THIS FORM 
You may be eligible to take part in a research study.  This form gives you 
important information about the study.  It describes the purpose of the study, and 
the risks and possible benefits of participating in the study.   
Please take time to review this information carefully.  After you have finished, you 
should talk to the researchers about the study and ask them any questions you 
have.  You may also wish to talk to others (for example, your friends, family, or 
other doctors) about your participation in this study.  If you decide to take part in 
the study, you will be asked to sign this form.  Before you sign this form, be sure 
you understand what the study is about, including the risks and possible benefits 
to you. 
1.  GENERAL INFORMATION ABOUT THIS STUDY AND THE 
RESEARCHERS 
1.1  Study title:  
The influence of vitamin D status on periodontal surgery outcomes: A prospective 
analysis. !
1.2  Company or agency sponsoring the study:  
Advance Grant Crosby Award. !
1.3  Names, degrees, and affiliations of the researchers conducting the 
study:  
Principal Investigator: Jill Bashutski, DDS, MS; Clinical Assistant Professor of Periodontics 
Co-Investigator: Laurie K. McCauley, DDS, PhD; Professor, School of Dentistry  
Co-Investigator: Ebone’ Jordan, DDS; Graduate Periodontics Resident, School of Dentistry!
 
2.  PURPOSE OF THIS STUDY 
2.1  Study purpose:  
Vitamin D is important for calcium regulation and proper immune function, which 
is important for good bone healing.  The purpose of this study is to compare 
clinical outcomes of periodontal surgery between vitamin D deficient and 
sufficient patients.  This research study is being done to learn what effect of 
!48!!
different vitamin D levels will have on clinical outcomes for patients receiving 
periodontal surgery.   
 
3.  INFORMATION ABOUT STUDY PARTICIPANTS (SUBJECTS) 
Taking part in this study is completely voluntary.  You do not have to participate 
if you don't want to.  You may also leave the study at any time.  If you leave the 
study before it is finished, there will be no penalty to you, and you will not lose 
any benefits to which you are otherwise entitled.   
 
3.1  Who can take part in this study? 
Healthy males and females, ages 30 to 85, with a diagnosis of a localized or 
generalized periodontal disease and a need for periodontal surgery can take part 
in this study.  If you take part in this study, you must be able and willing to follow 
study procedures and instructions.  In addition, you must have read, understood 
and signed the informed consent form. Female patients who are pregnant or 
breast-feeding will not be able to participate in this study.   
 
Patients who are heavy smokers (>1 pack per day), uncontrolled diabetes, or 
who are unable to attend regular follow up examinations are not eligible to 
participate in this study. 
 
It is very important that you provide complete and accurate information about 
your health condition/history in order to ensure that you are safe and appropriate 
candidates for participation. !
3.2  How many people (subjects) are expected to take part in this study? 
65 people are expected to take part in this study.  !
 
4.  INFORMATION ABOUT STUDY PARTICIPATION  
4.1  What will happen to me in this study?   
Non-experimental procedures: You are a candidate for periodontal surgery.  This 
surgery would be performed on you whether you participate in the study or not.   
 
You will receive a full dental examination, including having x-rays taken as 
necessary. 
 
All patients will receive periodontal surgery as was treatment planned by your 
health care provider. 
 
You will return for a post-operative visit 1-2 weeks after surgery.  Follow-up 
visits to assess if adequate healing has occurred will take place 3, 6, and 12 
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months after surgery.   
  
These procedures are the same regardless of whether you were in a study or not. 
 
Experimental procedures:  The following procedures will be performed only as 
part of the study, and not as part of the standard of care for periodontal surgery.  
Intra-oral photographs may be taken at all appointments.  These photographs will 
only capture images of the inside of your mouth and will not be identifiable to non-
dental personnel.   
 
At the surgery appointment the Investigators will thoroughly explain the study 
and discuss study details with you.  If you agree to participate in the study, you 
will have a blood draw.  Up to 5cc of blood will be drawn (about 1 teaspoon).   
 
4.2  How much of my time will be needed to take part in this study?   
Your participation will require about 30 minutes on the day of your surgical 
appointment.   In addition, we will be using the clinical information obtained from 
your follow up appointments over the next 12 months, although these procedures 
would be done whether or not you were in the study. !
4.3 When will my participation in the study be over?  
Your participation in the study will terminate the day of your periodontal surgery.!
 
5.  INFORMATION ABOUT RISKS AND BENEFITS  
5.1  What risks will I face by taking part in the study?  What will the 
researchers do to protect me against these risks? 
Having a routine blood draw is a well-established procedure that you could have 
done whether you were in this study or not.  The researchers will do their best to 
perform the blood draw in a manner that limits the risk of side effects.  Any side 
effects will be managed by the Investigator and other clinical care providers. 
 
Some side effects associated with blood draws include pain, bruising, redness, 
and/or swelling at the blood draw site.  Rarely, an infection can occur after having 
blood taken. 
 
As with any research study, there may be additional risks that are unknown or 
unexpected. 
 
5.2  What happens if I get hurt, become sick, or have other problems as a 
result of this research? 
The researchers have taken steps to minimize the risks of this study.  Even so, 
you may still have problems or side effects, even when the researchers are 
careful to avoid them. Please tell the researchers listed in Section 10 about any 
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injuries, side effects, or other problems that you have during this study.  You 
should also tell your regular doctors. 
 
5.3  If I take part in this study, can I also participate in other studies? 
 Being in more than one research study at the same time, or even at different 
times, may increase the risks to you.  It may also affect the results of the studies.  
You should not take part in more than one study without approval from the 
researchers involved in each study.   
 
5.4  How could I benefit if I take part in this study?  How could others 
benefit?   
You may not receive any personal benefits from being in this study.!!
However, you will receive $40 compensation for your time. 
 
Possible benefits of the research for society (or for future patients with 
periodontal disease) include understanding the impact of vitamin D deficiency on 
healing in the oral cavity.  The results of this study may contribute to our 
understanding of how healing occurs in the oral cavity and may change in the 
way millions of patients are treated, resulting in a significant improvement in their 
quality of life.   
 
5.5  Will the researchers tell me if they learn of new information that could 
change my willingness to stay in this study? 
Yes, the researchers will tell you if they learn of important new information that 
may change your willingness to stay in this study. If new information is provided 
to you after you have joined the study, it is possible that you may be asked to 
sign a new consent form that includes the new information. 
 
6.  OTHER OPTIONS  
6.1  If I decide not to take part in this study, what other options do I have? 
Your alternative option is to continue with your dental care plan without the blood 
draw associated with this research project.!
 
7.  ENDING THE STUDY 
7.1  If I want to stop participating in the study, what should I do? 
You are free to leave the study at any time.  If you leave the study before it is 
finished, there will be no penalty to you. You will not lose any benefits to which 
you may otherwise be entitled.  If you choose to tell the researchers why you are 
leaving the study, your reasons for leaving may be kept as part of the study 
!51!!
record. If you decide to leave the study before it is finished, please tell one of the 
persons listed in Section 10 “Contact Information” (below). 
 
7.2  Could there be any harm to me if I decide to leave the study before it is 
finished?  
No, although we may contact you by telephone to ask if you are having any 
adverse events as a result of your participation in the study. !
 
7.3  Could the researchers take me out of the study even if I want to 
continue to participate? 
Yes. There are many reasons why the researchers may need to end your 
participation in the study.  Some examples are: 
! The researcher believes that it is not in your best interest to stay in the 
study. 
! You become ineligible to participate. 
! Your condition changes and you need treatment that is not allowed while 
you are taking part in the study. 
! You do not follow instructions from the researchers. 
! The study is suspended or canceled. 
 
8.  FINANCIAL INFORMATION 
8.1  Who will pay for the costs of the study? Will I or my health plan be 
billed for any costs of the study?   
There will be very little cost to participating in this study.  All procedures related to 
the study will be performed at no cost to you.  Ask the researcher if you have any 
questions about bills, fees, or other costs related to this study. 
 
The study will pay for research-related items or services that are provided only 
because you are in the study.  If you are not sure what these are, see Section 4.1 
above or ask the researchers for a list.  If you get a bill you think is wrong, call the 
researchers’ number listed in section 10.1. 
You or your health plan will pay for all the things you would have paid for even if 
you were not in the study, like: 
• Health care given during the study as part of your regular care 
• Items or services needed to give you study drugs or devices 
• Monitoring for side effects or other problems 
• Treatment of complications  
• Deductibles or co-pays for these items or services. 
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If you do not have a health plan, or if you think your health plan may not 
cover these costs during the study, please talk to the researchers listed in 
Section 10 below or call your health plan’s medical reviewer. 
By signing this form, you do not give up your right to seek payment if you are 
harmed as a result of being in this study. !
The study will pay for research-related items or services that are provided only 
because you are in the study.  If you are not sure what these are, see Section 4.1 
above or ask the researchers for a list.  If you get a bill you think is wrong, call 
the researchers’ number listed in section 10.1. 
You or your health plan will pay for all the things you would have paid for even if 
you were not in the study, like: 
• Health care given during the study as part of your regular care 
• Items or services needed to give you study drugs or devices 
• Monitoring for side effects or other problems 
• Deductibles or co-pays for these items or services. 
If you do not have a health plan, or if you think your health plan may not 
cover these costs during the study, please talk to the researchers listed in 
Section 10 below or call your health plan’s medical reviewer. 
By signing this form, you do not give up your right to seek payment if you are 
harmed as a result of being in this study. 
 
8.2  Will I be paid or given anything for taking part in this study? 
Yes.  You will receive $40 cash immediately after the blood draw. 
 
8.3  Who could profit or financially benefit from the study results? 
The company whose product is being studied: vitamin D (multiple manufacturers). 
 
9.  CONFIDENTIALITY OF SUBJECT RECORDS AND AUTHORIZATION TO 
RELEASE YOUR PROTECTED HEALTH INFORMATION  
The information below describes how your privacy and the confidentiality of your 
research records will be protected in this study. 
9.1  How will the researchers protect my privacy? 
Research records will be kept in a separate research file that does not include 
names, registration numbers, or other information that is likely to allow someone 
other than the researchers to link the information to you.  Your research 
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information will be stored in a locked cabinet and will not be made a part of your 
regular medical record.  However, if the researcher orders any tests, the order 
and results may become part of your regular medical record. !
 
9.2  What information about me could be seen by the researchers or by 
other people?  Why?  Who might see it? 
Signing this form gives the researchers your permission to obtain, use, and share 
information about you for this study, and is required in order for you to take part 
in the study.  Information about you may be obtained from any hospital, doctor, 
and other health care provider involved in your care, including: 
• Hospital/doctor's office records, including test results (X-rays, blood tests, 
urine tests, etc.) 
• All records relating to your condition, the treatment you have received, and 
your response to the treatment 
• Billing information 
There are many reasons why information about you may be used or seen by the 
researchers or others during or after this study.  Examples include: 
• The researchers may need the information to make sure you can take part 
in the study.   
• The researchers may need the information to check your test results or 
look for side effects.   
• University, Food and Drug Administration (FDA), and/or other government 
officials may need the information to make sure that the study is done in a 
safe and proper manner.    
• Study sponsors or funders, or safety monitors or committees, may need 
the information to:  
o Make sure the study is done safely and properly 
o Learn more about side effects  
o Analyze the results of the study  
• Insurance companies or other organizations may need the information in 
order to pay your medical bills or other costs of your participation in the 
study. 
• The researchers may need to use the information to create a databank of 
information about your condition or its treatment. 
• Information about your study participation may be included in your regular 
UMHS medical record. 
• If you receive any payments for taking part in this study, the University of 
Michigan accounting department may need your name, address, social 
security number, payment amount, and related information for tax 
reporting purposes.  
• Federal or State law may require the study team to give information to 
government agencies. For example, to prevent harm to you or others, or 
for public health reasons. 
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The results of this study could be published in an article, but would not include 
any information that would let others know who you are.  
 
9.3  What happens to information about me after the study is over or if I 
cancel my permission? 
As a rule, the researchers will not continue to use or disclose information about 
you, but will keep it secure until it is destroyed.  Sometimes, it may be necessary 
for information about you to continue to be used or disclosed, even after you 
have canceled your permission or the study is over.  Examples of reasons for this 
include: 
• To avoid losing study results that have already included your information  
• To provide limited information for research, education, or other activities  
(This information would not include your name, social security number, or 
anything else that could let others know who you are.)  
• To help University and government officials make sure that the study was 
conducted properly 
As long as your information is kept within the University of Michigan Health 
System, it is protected by the Health System’s privacy policies.  For more 
information about these policies, ask for a copy of the University of Michigan 
Notice of Privacy Practices.  This information is also available on the web at 
http://www.med.umich.edu/hipaa/npp.htm. Note that once your information has 
been shared with others as described under Question 9.2, it may no longer be 
protected by the privacy regulations of the federal Health Insurance Portability 
and Accountability Act of 1996 (HIPAA).   
 
9.4  When does my permission expire?   
Your permission expires at the end of the study, unless you cancel it sooner. You 
may cancel your permission at any time by writing to the researchers listed in 
Section 10 "Contact Information" (below).   
 
10.  CONTACT INFORMATION 
10.1  Who can I contact about this study? 
Please contact the researchers listed below to: 
• Obtain more information about the study 
• Ask a question about the study procedures or treatments 
• Talk about study-related costs to you or your health plan  
• Report an illness, injury, or other problem (you may also need to tell your 
regular doctors) 
• Leave the study before it is finished 
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• Express a concern about the study 
 
Principal Investigator: Jill Bashutski, DDS, MS  
Mailing Address: University of Michigan School of Dentistry, 3349 Dent, 
Box 1078  








You may also express a concern about a study by contacting the Institutional 
Review Board listed below, or by calling the University of Michigan Compliance 
Help Line at 1-888-296-2481. 
 University of Michigan Medical School Institutional Review Board 
(IRBMED) 
2800 Plymouth Road 
Building 200, Room 2086 
Ann Arbor, MI 48109-2800 
Telephone: 734-763-4768  (For International Studies:  US Country Code: 
001) 
Fax: 734-763-1234 
e-mail: irbmed@umich.edu  
If you are concerned about a possible violation of your privacy, contact the 
University of Michigan Health System Privacy Officer at 1-888-296-2481. 
When you call or write about a concern, please provide as much information as 
possible, including the name of the researcher, the IRBMED number (at the top 
of this form), and details about the problem.  This will help University officials to 
look into your concern.  When reporting a concern, you do not have to give your 
name unless you want to. 
 
11.  RECORD OF INFORMATION PROVIDED 
11.1  What documents will be given to me? 
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Your signature in the next section means that you have received copies of all of 
the following documents: 
• This "Consent to be Part of a Research Study" document.  (Note: In 
addition to the copy you receive, copies of this document will be stored in 
a separate confidential research file and may be entered into your regular 
University of Michigan medical record.) 
• Other (specify):  !
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12.  SIGNATURES !
Research Subject: I!understand!the!information!printed!on!this!form.!!I!have!discussed!this!study,!its!risks!and!potential!benefits,!and!my!other!choices!with!____________________.!!My!questions!so!far!have!been!answered.!!I!understand!that!if!I!have!more!questions!or!concerns!about!the!study!or!my!participation!as!a!research!subject,!I!may!contact!one!of!the!people!listed!in!Section!10!(above).!!I!understand!that!I!will!receive!a!copy!of!this!form!at!the!time!I!sign!it!and!later!upon!request.!!I!understand!that!if!my!ability!to!consent!for!myself!changes,!either!I!or!my!legal!representative!may!be!asked!to!reTconsent!prior!to!my!continued!participation!in!this!study.!
!
Signature!of!Subject:!! !!!!!!!!!!!!!Date:!! ! ! !
!
Name!(Print!legal!name):!!!! ! ! ! ! ! ! !
!
Patient!ID:! ! Date!of!Birth:!! !
!
 
Principal Investigator (or Designee): I!have!given!this!research!subject!(or!his/her!legally!authorized!representative,!if!applicable)!information!about!this!study!that!I!believe!is!accurate!and!complete.!!The!subject!has!indicated!that!he!or!she!understands!the!nature!of!the!study!and!the!risks!and!benefits!of!participating.!
!
Name:!! ! Title:!! !
!
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